134 related articles for article (PubMed ID: 33141997)
1. CD34+ selected peripheral blood Stem Cell Boost (SCB) for Poor Graft Function (PGF) or mixed chimerism in pediatric patients, after hematopoietic stem cell transplantation: Results of a retrospective multicenter study.
Berger M; Faraci M; Saglio F; Giardino S; Ernestina Vassallo E; Prete A; Fagioli F
Pediatr Transplant; 2021 Aug; 25(5):e13909. PubMed ID: 33141997
[TBL] [Abstract][Full Text] [Related]
2. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
[TBL] [Abstract][Full Text] [Related]
3. Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation.
Fraint E; Farooki S; Klein E; Mauguen A; Prockop SE; Scaradavou A; Curran K; Cancio M; Spitzer B; Boelens JJ; Oved J; Harris A; O'Reilly RJ; Kernan NA
Transplant Cell Ther; 2023 Jan; 29(1):46.e1-46.e6. PubMed ID: 36210027
[TBL] [Abstract][Full Text] [Related]
4. Post-Transplant CD34
Chandra S; Bleesing JJ; Jordan MB; Grimley MS; Khandelwal P; Davies SM; Edwards S; Leemhuis T; Marsh RA
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1527-1529. PubMed ID: 29555312
[TBL] [Abstract][Full Text] [Related]
5. Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.
Haen SP; Schumm M; Faul C; Kanz L; Bethge WA; Vogel W
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2241-51. PubMed ID: 26272482
[TBL] [Abstract][Full Text] [Related]
6. CD34
Mainardi C; Ebinger M; Enkel S; Feuchtinger T; Teltschik HM; Eyrich M; Schumm M; Rabsteyn A; Schlegel P; Seitz C; Schwarze CP; Müller I; Greil J; Bader P; Schlegel PG; Martin D; Holzer U; Döring M; Handgretinger R; Lang P
Br J Haematol; 2018 Jan; 180(1):90-99. PubMed ID: 29205259
[TBL] [Abstract][Full Text] [Related]
7. Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.
Larocca A; Piaggio G; Podestà M; Pitto A; Bruno B; Di Grazia C; Gualandi F; Occhini D; Raiola AM; Dominietto A; Bregante S; Lamparelli T; Tedone E; Oneto R; Frassoni F; Van Lint MT; Pogliani E; Bacigalupo A
Haematologica; 2006 Jul; 91(7):935-40. PubMed ID: 16818281
[TBL] [Abstract][Full Text] [Related]
8. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
9. Fresh or Cryopreserved CD34
Ghobadi A; Fiala MA; Ramsingh G; Gao F; Abboud CN; Stockerl-Goldstein K; Uy GL; Grossman BJ; Westervelt P; DiPersio JF
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1072-1077. PubMed ID: 28323004
[TBL] [Abstract][Full Text] [Related]
10. Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients.
Satwani P; Jin Z; Duffy D; Morris E; Bhatia M; Garvin JH; George D; Bradley MB; Harrison L; Petrillo K; Schwartz J; Foley S; Hawks R; Baxter-Lowe LA; Cairo MS
Biol Blood Marrow Transplant; 2013 Apr; 19(4):552-61. PubMed ID: 23253557
[TBL] [Abstract][Full Text] [Related]
11. Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantation.
Sun YQ; Wang Y; Zhang XH; Xu LP; Liu KY; Yan CH; Liu ZY; Huang XJ
Ann Hematol; 2019 Aug; 98(8):1877-1883. PubMed ID: 31144019
[TBL] [Abstract][Full Text] [Related]
12. Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients.
Gonzalez-Vicent M; Perez A; Abad L; Sevilla J; Ramirez M; Diaz MA
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e85-90. PubMed ID: 20216238
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment.
Peters C; Matthes-Martin S; Fritsch G; Holter W; Lion T; Witt V; Höcker P; Fischer G; Dieckmann K; Handgretinger R; Klingebiel T; Gadner H
Leukemia; 1999 Dec; 13(12):2070-8. PubMed ID: 10602431
[TBL] [Abstract][Full Text] [Related]
14. Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.
Chewning JH; Castro-Malaspina H; Jakubowski A; Kernan NA; Papadopoulos EB; Small TN; Heller G; Hsu KC; Perales MA; van den Brink MR; Young JW; Prockop SE; Collins NH; O'Reilly RJ; Boulad F
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1313-23. PubMed ID: 17950918
[TBL] [Abstract][Full Text] [Related]
15. Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor.
Kawano Y; Takaue Y; Watanabe A; Takeda O; Arai K; Itoh E; Ohno Y; Teshima T; Harada M; Watanabe T; Okamoto Y; Abe T; Kajiume T; Matsushita T; Ikeda K; Endo M; Kuroda Y; Asano S; Tanosaki R; Yamaguchi K; Law P; McMannis JD
Blood; 1998 Nov; 92(9):3123-30. PubMed ID: 9787147
[TBL] [Abstract][Full Text] [Related]
16. Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis.
Cesaro S; Gazzola MV; Marson P; Calore E; Caenazzo L; Destro R; De Silvestro G; Varotto S; Pillon M; Zanesco L; Messina C
Am J Hematol; 2003 Feb; 72(2):143-6. PubMed ID: 12555220
[TBL] [Abstract][Full Text] [Related]
17. CD34 Stem Cell Boost in Pediatric Allogeneic Stem Cell Transplant Recipients: A Case Series and Review of Literature.
Bowman S; Stanek J; Bajwa R; Polishchuk V; Abu-Arja R; Rangarajan HG
Clin Hematol Int; 2023 Jun; 5(2-3):155-164. PubMed ID: 37027103
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease-A single center experience.
Kogel F; Hakimeh D; Sodani P; Lang P; Kühl JS; Hundsdoerfer P; Künkele A; Eggert A; Oevermann L; Schulte JH
Pediatr Transplant; 2021 Mar; 25(2):e13892. PubMed ID: 33098344
[TBL] [Abstract][Full Text] [Related]
19. Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
Tsai SB; Liu H; Shore T; Fan Y; Bishop M; Cushing MM; Gergis U; Godley L; Kline J; Larson RA; Martinez G; Mayer S; Odenike O; Stock W; Wickrema A; van Besien K; Artz AS
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1065-1072. PubMed ID: 26912055
[TBL] [Abstract][Full Text] [Related]
20. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]